ClinicalTrials.gg
Not yet recruitingNCT07915128NA-PLU-MALODOSUpdated Nov 4, 2026

Evaluation of a Program to Prevent Recurrences of Episodes of Acute Low Back Pain, Assisted by the Axomove Application

An interventional study of 2 exercises program supervised by a physical therapist via a digital application and Care as usual in Low Back Pain, sponsored by University Hospital, Bordeaux. Not yet recruiting. Open to participants aged 18 Years to 49 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by University Hospital, Bordeaux · Not applicable, Interventional, and Treatment

Updated Nov 4, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
194
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
All
01

Study summary

The purpose of this study is to demonstrate that the prescription of specific exercises, supervised by a numerical application, reduces the rate of recurrence of episodes of acute low back pain

Read the detailed description

The prevention of chronic low-back pain is a public health issue, particularly in view of the cost of work stoppages. The spontaneous incidence of recurrence after an initial episode of acute low-back pain is over 80% within three years. These recurrences form the basis for the transition to chronicity. Studies have shown the preventive potential of a specific exercise program, with a reduction in the recurrence rate from 80% over one year to 35% over 3 years. The development of telehealth tools opens up the possibility of implementing and evaluating such a preventive program in outpatient clinics. Confirmation, in a primary care context, of the preventive effects described will enable us to envisage recommendations based on a high level of scientific evidence.

This study will compare a group following French health insurance recommendations for the management of acute low back pain with a group following 2 recommended exercises supervised by a physical therapist via a digital application.

After checking eligibility criteria and signing a consent form, the patient will be randomized into one of the 2 groups. In the control group, the doctor will provide the patient with the health insurance recommendations. In the intervention group, the doctor will provide the patient with the health insurance recommendations and refer them to a physiotherapist who will train them in the 2 recommended exercises. The patient will be contacted every 3 months for 2 years to fill in questionnaires and ask about his absence from work.

02

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • low back pain
  • physical therapists
  • digital application
03

In context

Low Back Pain

2,884 studies on the registry are indexed under Low Back Pain; 483 are open to participants now.

This study's planned enrollment of 194 is above the median of 60 across 2,324 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 805 studies on the registry; 196 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Working adult patients,
  • Between 18 and 49 years,
  • Had an episode of acute common low-back pain in the month prior to inclusion and resolved at the time of inclusion attended to by one of the participating general practitioners
  • With a smartphone and able to use it or with an internet connection,
  • Agreeing with consulting a physical therapist participating in the study,
  • Affiliated to the french public welfare system,
  • With a signed consent

Exclusion criteria

Exclusion Criteria:

  • Persistence of work stoppage on day of inclusion,
  • Work stoppage due to low back pain lasting more than one month in the year preceding inclusion,
  • Suspicion of symptomatic low back pain based on the doctor's clinical examination,
  • Presence of another chronic pathology likely to result in non-participation in the procedure (depression, cardio-respiratory insufficiency, obesity with BMI ≥ 30),
  • Presence of a neoplasm or serious infection and any other condition that could lead to prolonged general deterioration of the patient's health,
  • Patient under guardianship
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
194 participants (estimated)

Study arms

  • Active comparator
    Control group

    The control group will apply French health insurance recommendations

    Other: Care as usual

  • Experimental
    Experimental group

    The experimental group will apply French health insurance recommendations and the 2 recommended exercises supervised by a physical therapist via the Axomove application

    Other: 2 exercises program supervised by a physical therapist via a digital application

Interventions

  • Other2 exercises program supervised by a physical therapist via a digital application

    The physical therapist will ask patients to carry out self-rehabilitation sessions, consisting of 5 to 6 sets of 20 to 25 repetitions for each of the two recommended movements. Patients will be encouraged to perform these exercises at least every other day-or daily, if possible-for a minimum duration of 12 weeks. The intervention will consist of 2 initial sessions with a physiotherapist, who will introduce specific exercises and-depending on the patient's adherence (monitored via the Axomove app)-may subsequently offer between 1 and 8 follow-up sessions.

  • OtherCare as usual

    The French national health insurance system (Assurance Maladie) provides recommendations for preventing the recurrence of lower back pain. These are outlined on the website https://www.ameli.fr/assure/sante/themes/lombalgie-aigue/traitement-prevention and via the "Activ'Dos" mobile application. In general, the approach involves encouraging patients to engage in physical activity, providing them with appropriate and reassuring information, and advising them to visit the website to select exercises-from among some sixty options-to perform. As in the experimental group, this procedure will be supplemented by the provision of a back-care guide, which reinforces the reassuring information delivered orally.

06

What researchers measure

Primary outcomes

  1. Proportion of recurrent patients

    Proportion of recurrent patients, i.e. declaring a new episode of acute low-back pain likely to result in work stoppage during the two-year follow-up period, with data collected every three months

    Time frame: From enrollment to the end of intervention at 24 months

Secondary outcomes

  1. Average quality of life measured between baseline and 24 months

    Quality of life will be assessed using EQ-5D-5L scale every three months (Day 0, Month (M)3, M6, M9, M12, M15, M18, M21, M24). Mean score of quality of life will be assessed.

    Time frame: From enrollment to 24 months

  2. Average pain measured between baseline and 24 months

    Changes in pain levels will be measured every 3 months using a numerical pain scale. This is a standard measure in clinical practice, which will allow for the assessment-throughout the study-of the intervention's effectiveness regarding changes in pain, based on the following question: "Rate the intensity of your pain over the last two days on a scale from 0 to 10 (where 0 = no pain, and 10 = the worst pain you can imagine)." Mean score of pain will be assessed.

    Time frame: From enrollment to 24 months

  3. Change from baseline in functional disability at 24 months

    Changes in functional disability related to low back pain will be measured using a validated scale-the Oswestry Disability Index, which consists of 10 items-at the beginning and end of the study (day 0 and month 24).

    Time frame: At 24 months

  4. Number of Participants with chronic low-back pain

    Occurrence of chronic low-back pain defined by permanent work cessation every three months (M3, M6, M9, M12, M15, M18, M21, M24)

    Time frame: From enrollment to 24 months

  5. Change from baseline in Pain Anxiety Symptoms at 24 months

    The Pain Anxiety Symptoms Scale, which consists of 20 items, is used to assess pain-related anxiety across four factors: fear/catastrophizing, cognitive anxiety, physiological symptoms, and escape or avoidance reactions. Changes in Pain Anxiety Symptoms from baseline at 24 months will be assessed.

    Time frame: At 24 months

  6. Change from baseline in Chronic Pain Self Efficacy at 24 months

    The French-Canadian Chronic Pain Self Efficacy Scale -which, in its short version, consists of 6 items-is used to assess one's sense of self-efficacy in managing chronic pain. Changes in Chronic Pain Self Efficacy from baseline at 24 months will be assessed.

    Time frame: At 24 months

  7. Change from baseline in Kinesophobia at 24 months

    The French-Canadian version of the Tampa Scale of Kinesophobia, which consists of 17 items, is used to assess the fear of movement. Changes in Kinesophobia from baseline at 24 months will be assessed.

    Time frame: At 24 months

  8. Change from baseline in Depression symptoms at 24 months

    The Center for Epidemiologic Studies Depression Scale, which consists of 20 items, is used to assess depressive symptomatology. Changes in Depression symptoms from baseline at 24 months will be assessed.

    Time frame: At 24 months

  9. Change from baseline in occupational stress at 24 months

    The Job Content Questionnaire, which consists of 31 items, is used to assess occupational stress across four factors: the degree of autonomy, psychological job demands, the seeking of support at work, and physical demands. It will be administered at the beginning and end of the study (at baseline and at 24 months). Changes in occupational stress from baseline at 24 months will be assessed.

    Time frame: At 24 months

  10. Pain-Related Coping Strategies and Beliefs before intervention

    Pain-related coping strategies and beliefs about pain will be explored through semi-structured interviews with a subsample of 15 patients per study group. Interviews will investigate participants' experiences of pain, the coping strategies they use, and their beliefs about pain before the intervention.

    Time frame: Before the intervention (Day 0 to Day 8)

  11. Pain-Related Coping Strategies and Beliefs after intervention

    Pain-related coping strategies and beliefs about pain will be explored through semi-structured interviews with a subsample of 15 patients per study group. Interviews will investigate participants' experiences of pain, the coping strategies they use, and their beliefs about pain after the intervention.

    Time frame: at 24 months

  12. Acceptability of the Intervention: Patient Expectations and Concerns

    The acceptability of the intervention will be explored through semi-structured interviews with a subsample of 15 patients per study group. Interviews conducted before the intervention will explore participants' expectations, anticipated benefits, and concerns regarding the proposed intervention.

    Time frame: Before the intervention (Day 0 to Day 8)

  13. Patient Experiences and Perceived Effectiveness of the Intervention

    Patient experiences of the intervention will be explored through semi-structured interviews with a subsample of 15 patients per study group. Interviews will investigate participants' experiences, perceived effectiveness, difficulties encountered during implementation, and suggestions for improving the program

    Time frame: at 24 months

  14. Physiotherapist Expectations and Concerns Regarding the Intervention

    The acceptability of the intervention will be explored through semi-structured interviews with a subsample of 10 physiotherapists in the intervention group. Pre-intervention interviews will explore physiotherapists' expectations, anticipated benefits, and concerns regarding implementation of the intervention.

    Time frame: Before the intervention

  15. Physiotherapist Experiences and Perceived Effectiveness of the Intervention

    Acceptance and adoption of the intervention will be explored through semi-structured interviews with a subsample of 10 physiotherapists in the intervention group. Interviews will investigate their experiences implementing the program, perceived effectiveness, difficulties encountered, and suggestions for improvement.

    Time frame: at 24 months

  16. Incremental Cost-Effectiveness Ratio per Quality-Adjusted Life-Year Gained

    The incremental cost-effectiveness ratio will be calculated as the difference in costs between the intervention and control groups divided by the difference in quality-adjusted life-years (QALYs) gained over 2 years. Healthcare costs will be estimated using data from the French National Health Data System (Système National des Données de Santé, SNDS), and QALYs will be estimated using responses to the EQ-5D-5L questionnaire

    Time frame: From enrollment to 24 months

  17. Costs to the French National Health Insurance System Associated With Low Back Pain-Related Sick Leave

    Costs associated with low back pain-related sick leave will be estimated in euros using data from the French National Health Data System (SNDS) and study-specific data. Costs will be estimated from the perspective of the French National Health Insurance system

    Time frame: From enrollment to 24 months

  18. Estimated 5-Year Net Financial Benefit of Nationwide Implementation of the Intervention

    The net financial benefit to the French National Health Insurance system of nationwide implementation of the intervention will be estimated over a 5-year horizon. The analysis will extrapolate cost estimates derived from SNDS data and published literature to estimate the financial impact of implementing the intervention across France.

    Time frame: 5-years

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07915128
Responsible party
Sponsor
First posted
Nov 4, 2026
Start date
Jan 31, 2027 (estimated)
Primary completion
Jan 31, 2030 (estimated)
Completion
Jan 31, 2030 (estimated)
Last update
Nov 4, 2026

Study contacts

Mathieu DE SEZE, MD, PhD
Contact
mathieu.de-seze@chu-bordeaux.fr
+33 5 56 79 55 16

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion